Skip to main content

Table 2 Secondary outcomes

From: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol

Outcome

Value in patients with acute lung injury

Detectable effect size

Respiratory compliance (ml/cmH2O)

57.8 (36.5)

27.8

Sequential organ failure assessment score

7.2 (4.2)

3.2

  1. Data presented as mean (standard deviation).
  2. A statistical analysis plan has been designed and is attached as Additional file 1.
Back to article page

Trials

ISSN: 1745-6215